Caprelsa is an anti-cancer medication belonging to a group of medications referred to as antineoplastics. It is further classified as a receptor tyrosine kinase inhibitors. It is indicated for treating medullary thyroid cancer when the disease is progressing or inducing symptoms, but a patient cannot undergo surgery. This drug slows down the growth of the cancer cells by impairing the growth of blood cells that supply cancer cells with oxygen and nutrients.
Drug Name: Caprelsa
Generic name: Vandetanib